Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
BACKGROUND: RTS,S/AS01(E) is the lead candidate pre-erythrocytic malaria vaccine. In Phase IIb field trials the safety profile was acceptable and the efficacy was 53% (95%CI 31%-72%) for protecting children against clinical malaria caused by P. falciparum. We studied CS-specific T cell responses in...
Автори: | Olotu, A, Moris, P, Mwacharo, J, Vekemans, J, Kimani, D, Janssens, M, Kai, O, Jongert, E, Lievens, M, Leach, A, Villafana, T, Savarese, B, Marsh, K, Cohen, J, Bejon, P |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2011
|
Схожі ресурси
Схожі ресурси
-
Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
за авторством: Ally Olotu, та інші
Опубліковано: (2011-01-01) -
A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E
за авторством: Ndungu, F, та інші
Опубліковано: (2012) -
Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children
за авторством: Olotu, A, та інші
Опубліковано: (2014) -
Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.
за авторством: Ally Olotu, та інші
Опубліковано: (2014-01-01) -
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
за авторством: Olotu, A, та інші
Опубліковано: (2011)